Skip to main content
. 2002 Mar;70(3):1310–1318. doi: 10.1128/IAI.70.3.1310-1318.2002

TABLE 2.

Biological activities of mutated LukF-PV and HlgB combined with LukS-PV, HlgA, or HlgC

F proteinc S protein activity (time [min])
Ca2+ entrya
Ethidium entryb
LukS-PV HlgA HlgC LukS-PV HlgA HlgC
LukF-PV 100 (2.5) 91 ± 3 (5) 61 ± 7 (5) 8.4 ± 0.4 (1) 5.2 ± 0.2 (2) 4.2 ± 0.3 (4)
LukF-PV (2 nM) 92 ± 2 (7.5) 80 ± 9 (7.5) 36 ± 19 (10) 4.7 ± 0.2 (3) 4.8 ± 0.2 (6) 2.5 ± 0.2 (7)
F Gly130Asp 83 ± 4 (10) 71 ± 10 (10) 0 1.4 ± 0.1 (10) 2.8 ± 0.2 (6) 0
F Gly131Asp 95 ± 3 (5) 91 ± 1 (5) 30 ± 5 (5) 2.6 ± 0.1 (6) 4.9 ± 0.3 (3) 0.8 ± 0.2 (6)
F ΔAsn123-Gly127 56 ± 9 (10) 91 ± 11 (10) 98 ± 21 (7.5) 1.1 ± 0.1 (20) 3.1 ± 0.3 (6) 2.6 ± 0.2 (3)
F ΔIle124-Asn126 96 ± 7 (2.5) 102 ± 17 (5) 109 ± 20 (2.5) 3.4 ± 0.3 (4) 5.1 ± 0.2 (3) 7.0 ± 0.5 (1)
F ΔIle124-Ser129 0 0 0 0 0 0
F ΔSer125-Gly127 99 ± 3 (2.5) 93 ± 3 (5) 96 ± 2 (2.5) 9.7 ± 0.2 (1) 5.0 ± 0.2 (2) 10.2 ± 0.2 (1)
F ΔSer125-Leu128 90 ± 13 (5) 90 ± 4 (5) 92 ± 6 (2.5) 2.7 ± 0.1 (5) 4.8 ± 0.3 (3) 5.6 ± 0.4 (1)
F ΔGly127-Ser129 101 ± 7 (2.5) 89 ± 4 (5) 88 ± 3 (2.5) 4.9 ± 0.4 (2) 4.6 ± 0.2 (2) 7.0 ± 0.4 (1)
F Ser129Ala 97 ± 1 (2.5) 90 ± 2 (5) 64 ± 7 (5) 8.2 ± 0.2 (1) 4.9 ± 0.1 (2) 5.0 ± 0.2 (4)
HlgB 88 ± 5 (5) 89 ± 4 (2.5) 78 ± 6 (2.5) 5.9 ± 0.4 (1) 3.8 ± 0.3 (2) 3.5 ± 0.2 (2)
HlgB (0.5 nM) 44 ± 16 (10) 83 ± 7 (5) 59 ± 12 (7.5) 3.0 ± 0.3 (3) 3 ± 0.4 (2) 3.0 ± 0.2 (3)
HlgB Gly130Asp 85 ± 6 (7.5) 87 ± 2 (5) 30 ± 11 (2.5) 3.5 ± 0.4 (2) 2.9 ± 0.3 (3) 0.9 ± 0.1 (7)
a

Fluorescence maxima as percentages from control ± standard deviations; time (minutes) necessary to reach the maximal fluorescence is shown in parentheses.

b

Rate of ethidium entry as a variation of fluorescence/minute; lag time (minutes) before the increase of fluorescence is shown in parentheses.

c

If not otherwise specified, protein concentrations were as follows: LukS-PV, 1 nM; HlgA, 2 nM; HlgC, 1 nM; LukF-PV as well as all LukF-PV mutants, 40 nM; HlgB and HlgB G130D, 5 nM.